Send to

Choose Destination
See comment in PubMed Commons below
World J Gastroenterol. 2009 Aug 21;15(31):3874-83.

Peroxisome proliferator-activated receptor-gamma is essential in the pathogenesis of gastric carcinoma.

Author information

Department of Pathology, The First Affiliated Hospital of Inner Mongolia Medical College, Huhhot 010059, Inner Mongolia Autonomous Region, China.



To investigate whether peroxisome proliferator-activated receptor gamma (PPAR-gamma) is expressed in human gastric carcinoma and whether PPAR-gamma is a potential target for gastric carcinoma therapy.


PPAR-gamma protein in gastric carcinoma was examined by immunohistochemistry. In the gastric carcinoma cell line MGC803, PPAR-gamma, survivin, Skp2 and p27 protein and mRNA were examined by Western blotting and real-time reverse transcription-polymerase chain reaction, respectively; proliferation was examined by MTT; apoptosis was examined by chromatin staining with Hoechst 33342 and fluorescence activated cell sorting (FACS). and cell cycle was examined by FACS; the knockdown of PPAR-gamma was done by RNA interference.


A high level of expression of PPAR-gamma was observed in human gastric carcinoma and in a human gastric carcinoma cell line MGC803. The PPAR-gamma agonist 15-deoxy-Delta12,14-prostaglandin J(2) (15d-PGJ(2)) inhibited growth, and induced apoptosis and G(1)/G(0) cell cycle arrest in MGC803 cells in a concentration-dependent and time-dependent manner. The effect of 15d-PGJ(2) on MGC803 cells was not reversed by the selective and irreversible antagonist GW9662 for PPAR-gamma. Furthermore, survivin and Skp2 expression were decreased, whereas p27 expression was enhanced following 15d-PGJ(2) treatment in a dose-dependent manner in MGC803 cells. Interestingly, we also found that small interfering RNA for PPAR-gamma inhibited growth and induced apoptosis in MGC803 cells. The inhibition of PPAR-gamma function may be a potentially important and novel modality for treatment and prevention of gastric carcinoma.


A PPAR-gamma agonist inhibited growth of human gastric carcinoma MGC803 cells by inducing apoptosis and G(1)/G(0) cell cycle arrest with the involvement of survivin, Skp2 and p27 and not via PPAR-gamma.

[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Baishideng Publishing Group Inc. Icon for PubMed Central
    Loading ...
    Support Center